Milestone Scientific Narrows Losses in Q3, Eyes Profitability
Milestone Scientific reported a net loss of $748,000 for the third quarter of 2026 alongside a 136% year-over-year surge in medical segment revenue, driven by expanding clinical adoption of its CompuFlo system.
🏢CompaniesPhoto: Motley Fool
Key points
- Q3 net loss narrowed to $748,000 from $1.2 million a year earlier.
- Medical segment revenue grew 136% year-over-year.
- Management expects to approach or achieve profitability in Q4 2026.
Q3 Financials and Cost Reductions
Milestone Scientific Inc. posted total revenue of $2.2 million for the third quarter of 2026, marking a sequential adjustment following a strong second quarter. Company leadership pointed to a disciplined approach to operations that reduced operating expenses by 15.3% and improved gross margins by 280 basis points to reach 72.3%. Consequently, the quarterly net loss narrowed significantly to $748,000 compared to $1.2 million during the same period in the previous year. Management also identified roughly $400,000 in supplementary annual savings.
Medical Segment Expansion and CompuFlo Adoption
The company's commercial progress was underscored by its medical division, where revenue more than doubled year-over-year. Growth was propelled by the clinical adoption of the CompuFlo system across major domestic healthcare networks, including Rothman Orthopaedics and Pain and Spine Specialists. To capture further market share, Milestone Scientific has built a commercial network consisting of over 500 U.S. sales leads, specialized sales professionals, and distribution partnerships aimed at federal healthcare systems such as the Department of Veterans Affairs and the Department of Defense.
Outlook and International Growth
Bolstered by cost cuts and pipeline expansion, executives reaffirmed their full-year revenue guidance and expressed expectations to approach or achieve profitability in the fourth quarter of 2026. Internationally, the firm secured regulatory clearance in Turkey with broader international expansion initiatives slated for early 2027. Additionally, the company filed a provisional patent application exploring a new application for the CompuFlo technology in intrathecal pump refills.
What to watch next: Monitor whether Milestone Scientific successfully hits its fourth-quarter profitability target and tracks further adoption within major orthopedic networks.
Source Motley Fool — fool.com/earnings/call-transcripts/2026/11/13/milestone-scientific-… ↗
Read next
🧠AI AnalysisFiserv Shares Climb Despite Disappointing Third-Quarter 2026 Metrics
Fiserv stock managed to gain ground following its third-quarter 2026 financial report, defying weaker-than-expected business outcomes and pressure on free cash flow.
🧠AI AnalysisWalmart Shares Waver Despite Topping Estimates as Growth Momentum Cools
Walmart posted third-quarter results that surpassed analyst expectations, though slower growth rates across key segments prompted market hesitation before the stock recov…
🧠AI AnalysisBitcoin Slips Below Key Support Level as Bearish Technical Structure Takes Hold
Bitcoin recently traded around $59,090 following a decisive breakdown below the crucial $62,000–$64,000 support zone, shifting short-term market momentum toward sellers.
🧠AI AnalysisBitcoin Tests Support Following Drop Below $60,000 Milestone
Bitcoin recently swept the $55,000 mark before rebounding toward the $59,100 region following a sharp decline that broke previous support levels on November 20.
🧠AI AnalysisEvaluating HF Sinclair and the Turning Oil Refining Cycle
HF Sinclair has experienced impressive expansion driven largely by its refining sector, but market observers suggest the cyclical peak may be near.
🧠AI AnalysisBitcoin Technical Outlook Signals Persistent Bearish Structure Despite Short-Term Bounce
Bitcoin remains constrained by a broader bearish pattern on short-term charts as dynamic trendline resistance caps recovery attempts. Although price recently rebounded fr…